View Older Stories View More Recent Stories

Nov 12, 2024 09:35AM Form SC 13G Lexeo Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Nov 4, 2024 04:26PM Form SC 13D GLYCOMIMETICS INC Filed by: Adage Capital Management, L.P.
Oct 22, 2024 04:15PM Form SC 13D/A Oruka Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Sep 30, 2024 11:02AM Great Gulf announces minority investment in new ownership group behind purchase of Killington Resort and Pico Mountain
Sep 25, 2024 04:22PM SEC Levies More Than $3.8 Million in Penalties in Sweep of Late Beneficial Ownership and Insider Transaction Reports
Sep 25, 2024 04:20PM Alphabet, Goldman Sachs and others to settle charges over late filings, SEC says
Sep 3, 2024 10:32AM Form N-PX Adage Capital Management For: Jun 30
Aug 30, 2024 09:54AM Form N-PX ADAGE CAPITAL PARTNERS For: Jun 30
Aug 15, 2024 10:11AM Adage Capital’s $10 Million Gift Launches UNCF’s Project ACCLAIM to Accelerate HBCU Student Pathways into Financial Services
Aug 14, 2024 09:39AM Form 13F-NT Adage Capital Management For: Jun 30
Aug 14, 2024 09:38AM Form 13F-HR ADAGE CAPITAL PARTNERS For: Jun 30
Jul 1, 2024 07:01AM Benitec Biopharma (BNTC) Announces Appointment of Kishen Mehta to its Board of Directors
Jul 1, 2024 07:00AM Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors
Jun 14, 2024 08:04AM Disc Medicine (IRON) Announces 4.94M Share Offering at $36/sh
Jun 14, 2024 08:03AM Disc Medicine Announces Underwritten Offering of Common Stock
Jun 3, 2024 04:30PM Form SC 13G/A ABEONA THERAPEUTICS INC. Filed by: Adage Capital Management, L.P.
May 15, 2024 10:49AM Form 13F-HR ADAGE CAPITAL PARTNERS For: Mar 31
May 15, 2024 10:49AM Form 13F-NT Adage Capital Management For: Mar 31
May 13, 2024 08:15AM Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
May 9, 2024 04:05PM Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates
May 9, 2024 07:30AM Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
May 8, 2024 04:16PM Form 4 ABEONA THERAPEUTICS INC. For: May 07 Filed by: Adage Capital Management, L.P.
May 8, 2024 06:30AM Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 3, 2024 07:30AM Abeona Therapeutics (ABEO) Prices 12.29M Share and Warrant Offering at $4.07/sh
May 3, 2024 07:30AM Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
May 1, 2024 05:09PM Form SC 13G/A EyePoint Pharmaceuticals Filed by: Adage Capital Management, L.P.
Apr 30, 2024 08:53PM Form SC 13G EyePoint Pharmaceuticals Filed by: Adage Capital Management, L.P.
Apr 22, 2024 04:16PM Form 3 EyePoint Pharmaceuticals For: Apr 18 Filed by: Adage Capital Management, L.P.
Apr 18, 2024 07:02AM Benitec Biopharma (BNTC) Announces $40M Placement at $4.80/sh
Apr 18, 2024 07:00AM Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
Apr 16, 2024 06:59AM Cullinan Therapeutics (CGEM) Announces $280M Placement at $19/sh
Apr 16, 2024 06:59AM Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
Apr 11, 2024 12:11PM Form SC 13G/A Benitec Biopharma Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Apr 11, 2024 07:02AM Century Therapeutics (IPSC) to Acquire Clade Therapeutics, Announces $60M Private Placement
Apr 11, 2024 07:00AM Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Apr 5, 2024 04:06PM Form SC 13D ARCA biopharma, Inc. Filed by: Adage Capital Management, L.P.
Mar 25, 2024 06:30AM Nkarta (NKTX) Prices $240M Share and Warrant Offering at $10/sh
Mar 25, 2024 06:30AM Nkarta Announces Pricing of $240 Million Underwritten Offering
Mar 21, 2024 04:05PM Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates
Mar 19, 2024 09:07AM Geron Corp (GERN) Prices $150M Share and Warrant Offering at $3/sh
Mar 19, 2024 09:07AM Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Mar 19, 2024 08:45AM Fate Therapeutics (FATE) Prices 14.55M Share Offering at $5.50/sh
Mar 19, 2024 08:44AM Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
Mar 18, 2024 08:07AM Spyre Therapeutics (SYRE) announced $180M private placement
Mar 18, 2024 08:00AM Spyre Therapeutics Announces $180 Million Private Placement
Mar 13, 2024 04:22PM Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing
Mar 12, 2024 06:33AM Regulus Therapeutics (RGLS) Enters $100M Oversubscribed Private Placement
Mar 12, 2024 06:32AM Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity
Mar 11, 2024 07:31AM Lexeo Therapeutics (LXEO) Announces Oversubscribed $95.0 Million Equity Financing
Mar 11, 2024 07:30AM Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing
View More Recent Stories View Older Stories